David Maya Email Address

Executive Vice President

Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 40 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement CelerionUas service offerings.

Highly qualified leader focused on strategy and execution of top line growth, P&L management and new business development. Offering outstanding sales, marketing, operations and managed care experience within key markets in the pharmaceutical industry (oncology, anti-infectives, dermatology and CV). Successful at negotiating solutions-driven, large-scale contracts with executive management of major corporations. Developed successful international operations throughout Europe, Latin America and Canada.